Brief: Genetron Health Reports Third Quarter 2020 Unaudited Financial Results And Provides Business Update
Nov 9 (Reuters) - Genetron Holdings Ltd GTH.O :
* GENETRON HEALTH REPORTS THIRD QUARTER 2020 UNAUDITED
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.02
* Q3 REVENUE ROSE 37.6 PERCENT TO RMB 112 MILLION
* Q3 LOSS PER SHARE $0.01 EXCLUDING ITEMS
* IN EARLY SCREENING FOR LIVER CANCER, WE PLAN TO FURTHER
RAMP UP
OUR COMMERCIALIZATION INITIATIVES IN CHINA
Source text for Eikon: ID:nGNX8MgWxR
Further company coverage: GTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetron Holdings
See all newsBrief: Genetron Holdings Requested That Trading Of Its ADSs On Nasdaq Be Suspended As Of Close Of Trading On March 28, 2024
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
Genetron surges on $126 mln deal to go private